# Low-dose Versus a High-dose Sublingual Buprenorphine Induction

> **NCT05944952** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Friends Research Institute, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT05944952
- **Lead sponsor:** Friends Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-10-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944952, "Low-dose Versus a High-dose Sublingual Buprenorphine Induction". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05944952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*